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Introduction: Peripheral nerves may fail to regenerate across tube implants because these lack the microarchitecture
of native nerves. Bone marrow mesenchymal stem cells (MSC) secrete soluble factors that improve the regeneration of
the peripheral nerves. Also, microstructured poly-caprolactone (PCL) filaments are capable of inducing bands of
Büngner and promote regeneration in the peripheral nervous system (PNS). We describe here the interaction between
PCL filaments and MSC, aiming to optimize PNS tubular implants.
Methods: MSC were plated on PCL filaments for 48 h and the adhesion profile, viability, proliferation and paracrine
capacity were evaluated. Also, Schwann cells were plated on PCL filaments covered with MSC for 24 h to analyze the
feasibility of the co-culture system. Moreover, E16 dorsal root ganglia were plated in contact with PCL filaments for
4 days to analyze neurite extension. Right sciatic nerves were exposed and a 10 mm nerve segment was removed.
Distal and proximal stumps were reconnected inside a 14-mm polyethylene tube, leaving a gap of approximately
13 mm between the two stumps. Animals then received phosphate-buffered saline 1×, PCL filaments or PCL filaments
previously incubated with MSC and, after 12 weeks, functional gait performance and histological analyses were made.
Statistical analyses were made using Student’s unpaired t-test, one-way analysis of variance (ANOVA) or two-way
ANOVA followed by Bonferroni post-test.
Results: MSC were confined to lateral areas and ridges of PCL filaments, aligning along the longitudinal. MSC showed
high viability (90 %), and their proliferation and secretion capabilities were not completely inhibited by the filaments.
Schwann cells adhered to filaments plated with MSC, maintaining high viability (90 %). Neurites grew and extended
over the surface of PCL filaments, reaching greater distances when over MSC-plated filaments. Axons showed more
organized and myelinized fibers and reinnervated significantly more muscle fibers when they were previously
implanted with MSC-covered PLC filaments. Moreover, animals with MSC-covered filaments showed increased
functional recovery after 12 weeks.
Conclusions: We provide evidence for the interaction among MSC, Schwann cells and PCL filaments, and we also
demonstrate that this system can constitute a stable and permissive support for regeneration of segments of the
peripheral nerves.* Correspondence: vtulio@biof.ufrj.br
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The peripheral nervous system (PNS) consists of a com-
plex network that extends throughout the body, main-
taining contact with virtually all tissues and organs [1],
and for this reason it is extremely vulnerable to injury.
Annually, over one million people worldwide suffer from
PNS lesions [2], and 120,000 patients a year in Brazil,
the USA and Europe are subjected to peripheral nerve
surgeries arising from domestic and traffic accidents,
and tumor compression of axons, among other causes
[3]. The PNS is capable of regenerating, even after a
complete transection of axons [4]. This regenerative cap-
acity is attributed to many factors, including Wallerian
degeneration, immune response, Schwann cells (SC),
extracellular matrix proteins, and the role of neurotro-
phins and gangliosides [5]. A critical step for the suc-
cessful regeneration of peripheral axons is the formation
of bands of Büngner, specialized structures formed by
aligned and proliferative dedifferentiated SC that consti-
tute a permissive pathway guide for the regenerative
axons [4, 6]. However, when the lesion is too long, re-
generation is not possible.
Synthetic conduits made from different materials have
been widely tested, aiming to improve the regenerative
capacity of the PNS [7, 8]. Among these, poly-caprolactone
(PCL) is one of the best-studied biodegradable materials
and has already been approved as a nerve scaffold by the
US Food and Drug Administration [9, 10]. The stability
against degradation, low melting point, and specific elastic
characteristics of PCL are useful properties for the
regeneration of extensive nerve tissue [11–13]. In addition
to these favorable characteristics, PCL microstructured
filaments were able to induce the formation of bands
of Büngner [14].
In the last few years, the therapeutic role of mesenchy-
mal stem cells (MSC), isolated from the bone marrow
and other tissues [15, 16], has been studied [17] due to
their tissue repair activity [18]. When transplanted in a
mild peripheral nerve injury, MSC increased the survival
of sensory and motor neurons, the proliferation of glial
cells, the axonal outgrowth, and the number and thick-
ness of myelinated fibers, and reduced muscle atrophy
[19–22]. This beneficial role is commonly attributed to a
paracrine effect of MSC due to the release of several fac-
tors by these cells. In addition, MSC can induce produc-
tion, by the host tissue, of soluble molecules such as nerve
growth factor (NGF), brain-derived neurotrophic factor
(BDNF) and fibroblast growth factor-2 (FGF-2), which act
directly on neurons and glial cells [19, 23–27], or vascular
endothelial growth factor (VEGF) and hepatocyte growth
factor (HGF), which promote angiogenesis and block the
formation of scar tissue, respectively [28].
One way of further stimulating the regenerative cellu-
lar responses triggered by a nerve injury is to combinethe use of conduits and cell therapies [2]. The first step
when combining MSC with different materials, in a con-
duit or filament guide, is to assess the interaction of the
cells with the material, since it is well known that chem-
ical [29], physical [30, 31] and biological [32] modifica-
tions of the culture environment can modify the cellular
behavior of MSC and, with that, their modulator effects
[18]. In this study, we investigated the interaction of
MSC with microstructured filaments of PCL as a possible
alternative for the regeneration of peripheral nerve tissue
in a model of severe sciatic nerve lesion. We observed that
MSC interacted with PCL microstructured filaments and
maintained cell properties including morphology, prolifer-
ation, CD90-positive phenotype, and trophic activity (ex-
pression and secretion of FGF-2). Moreover, the MSC/
PCL filaments supported the adhesion of SC derived from
regenerating nerve tissue and were able to support exten-
sive axonal regeneration of peripheral neurons in vitro. In
the in vivo experiments, we observed robust nerve tissue
replacement, reinnervation and motor functional recovery
12 weeks after the implantation of MSC/PCL filaments in
adult rats.Methods
PCL filaments
The PCL filaments used in this study were kindly do-
nated by Prof. Dr. Burkhard Schlosshauer of The Natural
and Medical Sciences Institute associated with the University
of Tübingen, in collaboration with the Institute of Textile
Technology and Process Engineering Denkendorf, Germany.
Synthetic absorbable filaments were made from PCL with a
molecular weight of 50,000 g/mol (Dow Tone, P767). Long
microstructured filaments were formed by a technique of
melting and extrusion in a spinneret at 205 °C, using a six-
leaf nozzle with 24 capillaries. The yield volume was approxi-
mately 0.4 ml/min for each capillary, and the output speed
was 1000 mm/min. In this state, the diameter of each capil-
lary was 22 μm, with 66 μm of functional circumference.
The bundles of filaments were washed with distilled water,
wrapped around a microscope slide to facilitate handling,
and the ends sealed. Small 2 cm segments (width of a micro-
scope slide) containing hundreds of filaments sealed at the
ends were sterilized in 70 % ethanol and dried [14]. Ultra-
structural analysis was carried out by bonding the specimens
in brackets covered with double-sided tape and imaging in
an scanning electron microscope (Jeol JSM6390LV, JEOL,
Peabody, MA, USA) after sputtering with a 20 nm thick gold
layer (Fig. 1a,b). The functionalization of the filaments was
performed in a three-step process. Initially, the material sur-
face was hydrophilized using a glow discharge O2 plasma for
three cycles of 75 s (PELCO easiGlow™, Pelco, Redding, CA,
USA). Then, the filaments were coated with poly-D-lysine
(50 μg/mL H2O; Sigma-Aldrich, São Paulo, SP, Brazil) and
Fig. 1 Setup for culture of PCL filaments with MSC or MSC with SC. a,b Scanning electron microscopy (ESM) photomicrographs of PCL filaments
showing in low (a) and high (b) magnification the microstructured grooves formed by melting extrusion at 60 °C. c Phase-contrast photomicrograph
and c’ fluorescence photomicrograph in higher magnification of mesenchymal stem cells (MSC) in culture after three passages. In c’ MSC expressed
enhanced green fluorescent protein (EGFP; green), and nuclei are labeled in blue (DAPI labeling). d Phase-contrast photomicrograph of Schwann cells
(SC) derived from adult sciatic nerve cultured for 10 days. d’ Fluorescence photomicrograph of SC immunostained for S-100 (red) and nuclei labeled
with DAPI (blue). The vast majority of cells are positive for S-100. e Photograph illustrating the culture system used, with a bundle of PCL filaments
treated with plasma-O2/poly-D-lysine/laminin and incubated with MSC or MSC plus SC for 48 h. Scale bars: a = 50 μm; b = 10 μm; c,d = 400 μm;
c’,d’ = 100 μm; e = 2 cm
Carrier-Ruiz et al. Stem Cell Research & Therapy  (2015) 6:128 Page 3 of 15then coated with laminin (5 μg/ml; Life Technologies,
Sao Paulo, Brazil).
Animals
All experiments were performed following the National
Institutes of Health Guidelines for the Care and Use of
Laboratory Animals and approved by the Ethics Committee
for the Use of Animals in Research from the Federal
University of Rio de Janeiro (CEUA IBCCF protocol # 158).
Lister hooded rats (3–5 months old) of both sexes were
used, with a mean weight of 250 g (n = 40), bred at our in-
stitution’s rodent facility and housed with free access to
food and water. In some experiments, we used Lewis rats
(LEW-Tg (EGFP) F455.5/Rrrc), in which enhanced green
fluorescent protein (EGFP) is expressed under the ubiquitinC promoter (n = 5); these rats were kindly donated by Dr.
Alexandre Leite Rodrigues de Oliveira from the State
University of Campinas, Brazil, and housed in our facilities.
Mesenchymal stem cell culture
Male Lister hooded and EGFP Lewis rats were deeply
anesthetized with an intraperitoneal injection of xylazine
(5 mg/kg Rompum; Bayer, São Paulo, SP, Brazil) and keta-
mine chloride (50 mg/kg Vetaset; Fort Dodge Laboratories,
New Jersey, NJ, USA) and killed by cervical dislocation.
The tibias and femurs were removed and cleaned of
muscle tissue, and the epiphyses were cut in a sterile
environment. The bone marrow was flushed from the
bones using 15 mL DMEM F-12 (Dulbecco’s modified
Eagle medium) with 10 % fetal bovine serum (FBS; Life
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and 100 μg/mL, respectively; Sigma-Aldrich) and glutam-
ine (1 mg/mL; Life Technologies), and the collected
cells were gently dissociated with a Pasteur pipette.
Cells (106 cells/cm2) were added to culture dishes (96 ×
21 mm; TPP, São Paulo, Brazil) and kept in an incuba-
tor with 5 % CO2 overnight at 37 °C. Nonadherent cells
were removed, and adhered cells were supplemented
with fresh culture medium three times a week. When
the culture dishes reached 75–90 % confluence
(Fig. 1c,c’), cells were trypsinized (0.25 % trypsin with
1 mM EDTA; Life Technologies), tested for viability
with Trypan blue (0.2 %; Life Technologies) and ex-
panded. MSC were used in experiments after 3 to 5
passages, with 75 to 90 % confluence [19].
Schwann cell culture
Male Lister hooded and EGFP Lewis rats were deeply
anesthetized as described above, then both sciatic nerves
were crushed at the mid-thigh level for 15 s. After 24 h
the animals were killed as described above and the
nerves were carefully removed. The aim of this proced-
ure was to activate SC at the distal stump after lesion,
since the axons were disrupted. In a sterile environment,
the epineurium was removed from the distal nerve
stumps under low-magnification microscopy, and small
pieces of nerve were removed with ophthalmic scissors.
Nerve explants were placed in culture dishes (60 ×
16 mm; TPP) with DMEM F-12, 20 % FBS, penicillin
and streptomycin and glutamine, for 1 week to allow SC
migration, with replacement of the culture medium
three times a week. After this period, the culture
medium was changed to 10 % FBS plus 10 ng/mL FGF-2
(Life Technologies) and 2 μM Forskolin (Sigma-Aldrich)
to stimulate SC proliferation [33, 34]. After 1–2 weeks
in this medium, the SC reached 75–90 % confluence and
were trypsinized, tested for viability with Trypan blue,
and expanded to poly-D-lysine- and laminin-coated cul-
ture dishes. SC were used in experiments after 1–5 pas-
sages, with 75–90 % confluence, and 80 % purity
(Fig. 1d,d’).
Cell culture on PCL filaments
A bundle of filaments (as above) was separated from the
main body and deposited on a microscope slide, in a
Petri dish (Fig. 1e). After PCL treatment with plasma-O2
and poly-D-lysine/laminin, three different MSC concen-
trations were seeded onto the filaments: 2 × 104 cells/mL
(n = 4), 2 × 105 cells/mL (n = 4) and 2 × 105 cells/mL
(n = 4), in a volume of 100 μL of culture medium, to
test the best concentration of MSC. MSC were kept
in culture for 48 h, with medium replacement every
24 h. A concentration of 2 × 105 cells/mL MSC was
used in all the remaining experiments.SC were also plated at a concentration of 2 × 105 cells/
mL for 48 h, when cultured alone, in a medium contain-
ing FGF-2 (10 ng/mL) and Forskolin (5 μg/mL). When
in co-culture with MSC on PCL filaments, the SC were
plated at a concentration of 105 cells/mL, 24 h after the
MSC plating, and were kept in culture for 24 h. In some
experiments, before the co-culture, SC were incubated
with the fluorescent marker CellTrace™ Far Red DDAO-
SE (1:500; Life Technologies), for 40 min in an incubator
with 5 % CO2 at 37 °C and then washed three times for
5 min each. In control experiments, to better evaluate
the influence of the three-dimensional environment of
the PCL filaments, we used a conventional culture of
MSC, in which cells were plated on glass slides treated
with poly-D-lysine and laminin and maintained in cul-
ture as long as the filaments were incubated with MSC.
After 48 h of co-culture of the filaments with the MSC,
they were washed with phosphate-buffered saline (PBS) 1×
and fixed with 4 % paraformaldehyde (4 % PFA in 0.1 M
phosphate buffer, pH 7.4) for 20 min. Immunostaining was
performed for the CD90 membrane antigen (Thy-1)
present in MSC. The filaments were then separated by the
edges, spread on a microscope slide, mounted with Vecta-
shield (Vector, Burlingame, CA, USA) and analyzed by con-
focal microscopy (LSM 510 META, Zeiss, Jena, Germany).
The number of MSC that adhered directly to the filaments
or to other cells, as well as the total number of MSC, were
quantified and normalized per millimeter of filament and
compared among the different experimental groups.
To assess cell viability, the LIVE/DEAD® Viability/
Cytotoxicity (Life Technologies) kit was used. After 48 h
of cultivation with filaments, the MSC (n = 4) or MSC
and SC co-culture (n = 4) were washed once with PBS
1× and incubated with green fluorescent calcein-AM
(1:5000) and red fluorescent ethidium homodimer-1
(1:1000) in 1× PBS for 10 min in an incubator with 5 %
CO2 at 37 °C. Then, the filaments were washed with
PBS 1× and the cells analyzed by epifluorescence mi-
croscopy for live cells (EVOS®, Life Technologies). The
ratio between the number of viable cells and total cell
number was calculated and compared among the differ-
ent experimental groups.
To investigate cell proliferation, after 48 h, MSC
grown on glass coverslips (n = 8) and on PCL filaments
(n = 8) were washed, fixed as described above, and im-
munostained for Ki-67, a marker of proliferating cells
that is present in all phases of the cell cycle, except G0.
After that, the filaments were separated by the edges,
spread on a microscope slide, mounted with Vectashield
(Vector) and analyzed by confocal microscopy (LSM 510
META, Zeiss). The number of Ki-67+ cells was counted
and the ratio between this number and the total number
of cells was calculated and compared among the differ-
ent experimental groups.
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ing and fixation of the co-cultures of the filaments with
MSC. After that, the filaments were separated by the
edges, spread on a microscope slide, mounted with Vec-
tashield (Vector), and analyzed by confocal microscopy.
The levels of FGF-2 protein in supernatants from MSC
cultures on coverslips or PCL filaments maintained in
complete DMEM F-12 medium were determined by
enzyme-linked immunosorbent assay (ELISA) using the
Quantikine Human FGF-2 Immunoassay (R&D Systems,
Mineapolis, MN, USA) in accordance with the manufac-
turer’s instructions.
Dorsal root ganglia explant culture and neurite extension
Dorsal root ganglia (DRG) explants were obtained from
E16 embryos. Pregnant rats were anesthetized and killed
as described previously, and the embryos were immedi-
ately removed. DRG were dissected and then incubated in
culture medium (as above) containing NGF (50 ng/mL;
Life Technologies) for 1 h at 37 °C and 5 % CO2 before be-
ing plated onto the filaments (incubated or not with cells)
in a 24-well plate (TPP) previously coated with poly-D-
lysine and laminin. The system was maintained in culture
for 4 days and the medium was replaced on the third day.
After that, DRGs on glass coverslips (n = 11), on PCL fila-
ments (n = 14), on PCL covered with MSC (n = 15), and
on PCL covered with MSC plus SC (n = 16) were carefully
washed and fixed as described below. Immunostaining for
NF-200 was performed and the samples were mounted
directly on a microscope slide with Vectashield and ana-
lyzed by confocal microscopy. The maximum distance of
neurite extension from the center of the DRG was mea-
sured and quantified by Image-J 1.48v software (National
Institutes of Health, Bethesda, MD, USA) and compared
among the different experimental groups.
Immunostaining procedures
After fixation with 4 % PFA, the samples were washed
three times for 5 min each with PBS with Triton X-100
(0.1 % or 0.3 % for cytoplasm and nuclear antigens) or
without (for membrane antigens) and incubated with 5 %
Normal Goat Serum (NGS) in these solutions for 30 min
at room temperature. Incubation with primary antibodies
was performed for 2 h at room temperature, or overnight
at 4 °C, followed by three washes with washing solution.
Incubation with secondary antibodies and TO-PRO-3 nu-
clear dye (1:1000; Life Technologies) was performed in
blocking solution for 2 h at room temperature and washed
three times. Samples were mounted on microscope slides
with Vectashield (Vector). Primary antibodies used: mouse
monoclonal anti-CD90 (1:100; BD Biosciences, São Paulo,
SP, Brazil); rabbit polyclonal anti-GFAP (1:400; Dako,
Glastrup, Denmark); rabbit polyclonal anti-KI67 (1:400;
Abcam, Cambridge, MA, USA); chicken anti-GFP (1:1000;Life Technologies); mouse monoclonal anti-FGF-2 (1:50,
Millipore, Dallas, TX, USA); goat polyclonal anti-MBP
(1:200; Santa Cruz Biotechnology, Jackson Laboratories,
Jackson Imunno Research, West Grove, PA, USA); and
rabbit polyclonal anti-NF-200 (1:200; Sigma-Aldrich).
Secondary antibodies used: goat anti-mouse Cy3 (1:1000;
Jackson Laboratories, Jackson Imunno Research, West
Grove, PA, USA); goat anti-mouse Alexa Fluor 488
(1:1000; Life Technologies); goat anti-rabbit Alexa Fluor
555 (1:1000; Life Technologies); goat anti-chicken Alexa
Fluor 488 (1:1000; Life Technologies); and donkey anti-
goat Alexa Fluor 594 (1:800; Life Technologies). In these
reactions, the PCL filaments were revealed by reflected
light from the confocal microscope laser.
Sciatic nerve lesion and PCL filament implantation
Total transection and connection of the sciatic nerve was
performed under anesthesia as described above. The right
sciatic nerves were exposed at the mid-thigh level, and an
approximate 10 mm nerve segment was sectioned and re-
moved. Distal and proximal stumps were reconnected and
sutured inside a 14 mm polyethylene tube, leaving a gap
of approximately 13 mm between the two stumps inside
the tube. One group of rats received only 20 μL of PBS 1×
injected into the tube (n = 3), and another group had the
tube filled with PCL filaments coated with poly-D-lysine
and laminin (n = 3). A third group was implanted with
PCL filaments previously incubated with MSC (n = 3, 2 ×
106 cells/ml). PCL filaments were inserted into the tube
using small tweezers. After the animals recovered from
anesthesia, they were returned to the animal facility and
kept with food and water ad libitum for 12 weeks.
Behavioral tests
The functional performance of the animals was assessed
using the CatWalk locomotion analysis system (Noldus
Information Technology, Wageningen, Netherlands). Be-
fore surgery, the animals were trained daily for 2 weeks
on a walkway of 1.5 m to conduct two uninterrupted
consecutive runs along the walkway. Both during the
training periods and after the surgery, the animals were
motivated to cross to the other end of the walkway by
the presence of a food pellet. The animals were starved
for 4 h before each training period. At the end of the
2 weeks of training, all animals were making runs with-
out interruptions, lasting between 2 and 4 s. After sur-
gery, the animals were evaluated once a week, for
12 weeks; the day before each evaluation, animals were
starved overnight [35]. Runs of each animal were re-
corded by the CatWalk apparatus, and the recorded data
(at least two runs per animal) were analyzed with version
10.0 of the CatWalk program. The parameters analyzed
were area and maximum intensity of the footprint, and
swing speed of the paw. Values for all paws were
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paw for each parameter was calculated and compared
among the different experimental groups.
Histology procedures
Twelve weeks after surgery, rats were deeply anesthe-
tized as described above and perfused with a 0.9 % saline
solution for 10 min (10 mL/min; Masterflex, Cole-Palmer
Instrument Co., East Bunker Court Vernon Hills, IL, USA)
followed by 4 % PFA (20 min) and then 4 % PFA + 10 % su-
crose solution (10 min). Ipsilateral sciatic nerves, DRGs
(L5), lumbar spinal cord, and gastrocnemius muscles were
removed and kept in a 30 % sucrose solution in phosphate
buffer for 48 h. The nerves had the epineurium removed
and were photographed under a magnifying glass (Leica
S8AP0, Leica Microsystems, Nussloch GmbH, Wetzlar,
Germany). After embedding in OCT mounting medium,
longitudinal sections (20 μm) of the sciatic nerves and
muscles were obtained using a cryostat (Leica CM 1850,
Leica Microsystems, Nussloch GmbH) and mounted dir-
ectly on gelatin + 0.05 % chromium alum pre-coated
slides. Slides were stored at −20 °C for immunofluor-
escence procedures. For motor endplate analysis, we
employed the immunofluorescence procedure for NF-
200, followed by incubation with α-Bungarotoxin
conjugated with Alexa 555 (1:200; Life Technologies).
For semi-thin sections the animals were anaesthetized
using ketamine (100 mg/kg) and xylazine (15 mg/kg) and
euthanized via transcardial perfusion using a fixative solu-
tion (4 % PFA and 2 % glutaraldehyde in 0.1 M phosphate
buffer, pH 7.4). After perfusion, the sciatic nerve was col-
lected. The middle segments of the nerves were immersed
for 2 h in a solution of 2.5 % glutaraldehyde in 0.1 M
phosphate buffer (pH 7.4), washed with 0.1 M cacodylate
buffer (pH 7.4) and post-fixed for 90 min in 1 % osmium
tetroxide containing 0.8 % potassium ferrocyanide and
5 mM calcium chloride in 0.1 M cacodylate buffer
(pH 7.4). The segments were then washed in 0.1 M caco-
dylate buffer (pH 7.4) and stained with 1 % uranyl acetate
overnight in the dark. The next day, the nerves were dehy-
drated using increasing concentrations of acetone (from
30 % to 100 %), infiltrated with Embed-812 resin (Electron
Microscopy Sciences, Hatfield, PA, USA) and polymerized
at 60 °C for 48 h. Semi-thin (500 nm) transverse sections
were generated using an RMC MT-6000 ultramicrotome,
Sorvall, Milton Freewater, OR, USA. The semi-thin sec-
tions were stained with 1 % Toluidine Blue and examined
using a light microscope (Zeiss Axiovert).
Image processing and statistical analysis
Images were processed using the Image-J 1.48v program
(National Institutes of Health) and all data were analyzed
using GraphPad Prism 5 (GraphPad Software, Inc., La
Jolla, CA, USA). Statistical analyses were performed usingStudent’s unpaired t-test, one-way analysis of variance
(ANOVA) followed by Bonferroni post-test for compari-
son of all pairs of columns, and two-way ANOVA
followed by Bonferroni post-test comparing all pairs of
columns. The confidence interval was 95 %, and all values
are expressed as ± standard error of the mean (SEM).
Results
Cell adhesion and viability in the presence of PCL
filaments
To study the interaction between MSC and PCL fila-
ments, a custom culture system was developed, consist-
ing of a bundle of filaments deposited on a microscope
slide in a Petri dish (Fig. 1e). Using this system, we first
evaluated the interactions of MSC with the PCL fila-
ments. After 48 h in culture, numerous CD90-positive
cells were found in contact with the filaments (Fig. 2a),
mainly over the ridges and longitudinally aligned, as seen
in orthogonal planes with confocal microscopy (Fig. 2b).
Furthermore, three-dimensional reconstruction of op-
tical planes revealed that, although the cell nuclei were
located on the ridges, the cell bodies and processes ex-
tended toward the grooves (Fig. 2c), thereby enlarging
the area covered by the cells on the filaments.
We evaluated the best concentration of MSC by using
three different cell densities and counting the number of
cells in contact with the filaments (Fig. 2d). As the MSC
plating number increased, so did the number of cells that
were able to adhere to the material (Fig. 2d; p < 0.0001, no
statistical difference between 2 × 105 and 8 × 105 cells,
ANOVA). Evaluation of the cells longitudinally aligned with
the filaments showed that the number of cells decreased as
the plating number was increased, because with the highest
density MSC adhered to each other instead of to the fila-
ments (Fig. 2e; p < 0.0001, no statistical difference between
2 × 104 and 2 × 105 cells, ANOVA). Therefore, for the sub-
sequent experiments, the plating concentration of 2 × 105
cells (Fig. 2a) was chosen to maximize adhesion to and
alignment with the PCL filaments.
The next step was to evaluate if the new culture envir-
onment would lead to alterations in MSC viability.
Forty-eight hours after plating, the majority of MSC
were stained with calcein-am (Additional file 1: Figure
S1A), whereas only a few were stained with ethidium
homodimer-1 (Additional file 1: Figure S1C), indicating
high cellular viability. In a similar way, the viability of
the system was also tested when SC were co-cultured
with MSC. Again, the majority of the cells were stained
with calcein-am (Additional file 1: Figure S1B), whereas
only a few were stained with ethidium homodimer-1
(Additional file 1: Figure S1D). The MSC and SC could
be distinguished from each other because SC were pre-
viously incubated with CellTrace (Additional file 1:
Figure S1F). Merged images of MSC culture and MSC
Fig. 2 Cell adhesion and viability in the presence of poly-caprolactone (PCL) filaments. a, b Confocal microscopy optical sections of mesenchymal
stem cells (MSC) incubated at medium density (2 × 106 cells/mL) for 48 h on PCL filaments immunolabeled for CD90. b Orthogonal projections of
Z-stack in high magnification, showing an individual PCL filament covered by two MCS. c Three-dimensional reconstruction by confocal microscopy of
a single MSC (surface view) on an isolated PCL filament. d Quantitative analysis of the number of CD-90+ cells in contact with the PCL filaments and
e the percentage of MSC aligned with the PCL filaments. f Percentage of viable cells in the different experimental conditions. Scale bars: a = 100 μm;
b, c = 50 μm. ***p < 0.0001 by ANOVA. SC Schwann cells
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S1G and Figure S1H. Also, there was no CellTrace
staining in the MSC culture alone (Additional file 1:
Figure S1E), as only the SC were previously incubated
with CellTrace. As demonstrated by the quantitative
analysis (Fig. 2f ), the cells displayed high viability in
the different experimental conditions.
Proliferation and trophic activity of MSC in the presence
of PCL filaments
To assess the cellular behavior of MSC plated on PLC
filaments, the proliferation and expression of FGF-2, a
trophic factor, was evaluated (Fig. 3). The number of
cells that were positive for Ki-67 was used to quantify
the proliferating cells. When MSC were cultured alone
on coverslips, approximately 35 % of the cells were posi-
tive for Ki-67 (Fig. 3a,b,f ). When the same cells were co-
cultured with PCL filaments, the number of proliferatingcells was reduced to approximately 10 % (Fig. 3d,e,g;
p < 0.0001, Mann-Whitney).
The expression of FGF-2 by the MSC was investigated
by immunostaining, and the release of FGF-2 to the cul-
ture medium was measured by ELISA. MSC expressed
FGF-2 both alone and when in the presence of filaments
(Fig. 3c,f ). The amount of FGF-2 in the culture medium
was reduced when MSC were co-cultured with the fila-
ments (Fig. 3g; p < 0.001, Mann-Whitney).
MSC/PCL biomaterial promotes neurite outgrowth of DRG
neurons
DRGs were cultured over MSC/filaments to investigate a
possible effect on neurite outgrowth. Neurites were im-
munostained for NF-200, and their maximum length
was evaluated in the different culture conditions (Fig. 4).
When DRGs were plated on coverslips, we observed a
halo of NF-200-positive neurites extending radially from
Fig. 3 Cell proliferation and fibroblast growth factor-2 (FGF-2) expression in the presence of poly-caprolactone (PCL) filaments. a–f Confocal
microscopy optical sections of enhanced green fluorescent protein (EGFP)-mesenchymal stem cells (MSC) cultured for 48 h on a coverslip (a–c)
or on PCL filaments (d–f) immunolabeled for KI-67 (red) (a, b, d, e) or FGF-2 (c, f). Cell nuclei were stained with To-Pro (blue). g Quantitative
analysis showing the percentage of KI-67+ MSC on a coverslip or PCL filaments. h Quantitative analysis of the FGF-2 concentration (pg/mL) detected
by ELISA assay in the conditioned medium from MSC cultures on a coverslip or with PCL filaments. Scale bars: a–f = 100 μm. ***p < 0.0001,
**p < 0.001, Mann-Whitney
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(Fig. 4b,c) we observed a preferential outgrowth of the
neurites following the filaments (Fig. 4c). Most of the
neurites were aligned with the filaments, and the max-
imum distance of neurite growth from the explant was
twice that observed in DRGs plated on coverslips (Fig. 4a;
p < 0.05, ANOVA). When the filaments were previously
incubated with MSC (Fig. 4d) or with MSC + SC (Fig. 4e),
the neurites extended over even longer distances
compared with the DRG plated on coverslips (fourfold;
p < 0.0001, ANOVA) or plated on PCL filaments alone
(twofold; p < 0.001, ANOVA). There was no statistical
difference between MSC and MSC + SC (Fig. 4i). We
also counted the number of neurites at a distance of
500 μm from the explant (Fig. 4j). The largest number
of neurites was observed in the presence of filaments
plus MSC and SC (Fig. 4j). At higher magnification, we
observed that DRG neurons extended neurites over mi-
grated SC (GFP−, thick arrow) on the filaments, and
were also in direct contact with the MSC (GFP+, thin
arrow) on the filaments (Fig. 4f–h).
The implantation of PCL/MSC biomaterial in adult rats
improves nerve regeneration
For in vivo experiments, the experiment for implantation
of PCL filaments into a polyethylene tube reconnectingboth stumps (13 mm gap) after sciatic nerve transection
was designed according to the illustrations in Fig. 5a’–c’.
Morphological macroscopic and quantitative analysis
of the sciatic nerves in the three different experimental
conditions showed important differences among the
groups in the tissue present in the gap; regenerated tis-
sue was present in the groups with filaments but only a
thin regenerated tissue was observed in the PBS group
(Fig. 5a–c,m). However, the group with filaments plus
MSC had a thicker regeneration compared to the group
with filaments (Fig. 5m; p < 0.001). Quantitative analysis
of tissue sections of the three groups revealed a larger
number of cells in the regenerated region in the group
with the filaments covered with MSC, compared with
the PBS group and filaments group (Fig. 5d–f,n). Due to
the Wallerian degeneration, the cell density in all the ex-
perimental groups was raised compared to the unle-
sioned nerves. The presence of axons in this tissue was
investigated by NF-200 staining, and more and better or-
ganized axons were present in the groups with filaments
(Fig. 5g–i). Quantitative analysis demonstrates signifi-
cantly increased axonal density in rats which received
filaments covered with MSC compared to the filaments
(0.4-fold; p < 0.01) and PBS group (1.6-fold; p < 0.001),
respectively (Fig. 5o). Nerve tissue sections were also im-
munostained for S100 (not shown) and myelin basic
Fig. 4 Neurite outgrowth from dorsal root ganglia (DRG) explants in the different culture conditions. a–e Confocal microscopy images of E16 rat
DRG explants placed on a coverslip (a), on poly-caprolactone (PCL) filaments (c), on PCL filaments +msenshymal stem cells (MSC) (d), and on PCL
filaments + MSC + Schwann cells (SC) (e) and cultured for 72 h. Neurites are identified by immunolabeling with NF-200 (green) and cell nuclei
with To-Pro (blue). b Nomarski DIC image showing the organization of PCL filaments in these experiments. Dashed circles illustrate the area
where DRGs were placed (b–e). f–h High-magnification confocal optical sections showing enhanced green fluorescent protein (EGFP) + MSCs
(green) on PCL filaments (f) 72 h after incubation with DRG (thick arrows indicate MSC-EGFP and thin arrows indicate migrated non-MSC on PCL
filaments). In (g), neurites were immunolabeled for NF-200 (red) and the merged image reveals neurites growing aligned in close association with
MSC (h, arrows). i,j Histograms of quantitative analysis of maximum neurite extension (i) and neurite density on PCL filaments at 500 μm from
DRG (j) after 72 h of incubation. Scale bars: a = 400 μm; b–e = 200 μm; f–h = 50 μm. *p < 0.01, **p < 0.001, ***p < 0.0001, ANOVA
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We observed MBP staining in all three groups, although
in different patterns. In the PBS group, MBP expression
was associated with cells at the periphery of the tissue
(Fig. 5j), while in the filament groups the staining
showed an elongated pattern, suggesting expression by
myelinating SC associated with axons (Fig. 5k,l). Weobserved in the transversal semi-thin section of the re-
generated nerves a progressive improvement in the tis-
sue organization 12 weeks after lesion (Fig. 5p–s). The
staining with toluidine blue revealed that the nerve hist-
ology of the animals receiving the filaments covered with
MSC was similar to uninjured nerves, 12 weeks after le-
sion. Myelinating fibers can be easily observed in this
Fig. 5 (See legend on next page.)
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Fig. 5 Regeneration of sciatic nerve after mesenchymal stem cell (MSC)/poly-caprolactone (PCL) implants. a’–c’ Schematic diagrams to illustrate
the three in vivo experimental groups. a’ Tube with PBS; b’ tube with PCL filaments; c’ tube with PCL filaments plus MSC. a–c Low-magnification
images of the sciatic nerves inside the tubes 12 weeks after surgery in the three conditions. Dashed squares indicate the areas imaged in d–l. d–l
Longitudinal sections of the sciatic nerve tissue immunolabeled for NF-200 (g–i, green) and myelin basic protein (MBP) (j–l, red) with cell nuclei
stained with To-Pro (d–f, blue). m–o Histograms of the quantitative analysis of the nerve thickness (m), cell density (n) and axonal density (o). p–s
Photomicrographs by optical microscopy in high magnification of the semi-thin section of the regenerated nerves, 12 weeks after lesion and im-
plantation stained with toluidine blue. Calibration bars: a–c = 5 mm; d–l = 100 μm; p–s = 20 μm. **p < 0.001, ***p < 0.0001, ANOVA; n = 6 animals
for each experimental condition
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Taken together, these data demonstrate that bioengineered
PCL filaments plus MSC promote consistent nerve tissue
replacement with regular cell density, axonal regeneration,
and myelinating SC replacement.
One important question is whether the regenerated
axons are able to reinnervate the muscle. To answer this
question, we obtained longitudinal sections of lateral
gastrocnemius muscle, a main target of the sciatic nerve,
and we double-labeled them with anti-NF-200 and with
α-bungarotoxin (which binds strongly to the acetylcho-
line receptor) (Fig. 6a–c). The quantitative analysis dem-
onstrated 63 % more motor endplates (α-bungarotoxin
+/NF-200+) in the MSC group compared to the tube
group, and 42 % more than in the filament group
(Fig. 6d; p < 0.0001, ANOVA). At high magnification, we
isolated individual motor endplates and compared the
morphology of those from all experimental conditions
with the muscle of unlesioned animals. Clearly, the MSCFig. 6 Motor endplate reinnervation. a–c Low-magnification images of lon
α-bungarotoxin conjugated with Alexa 555 (red) 12 weeks after sciatic nerv
or tube + PCL filaments covered with mesenchymal stem cells (MSC) (c). Ce
background of α-bungarotoxin which indicates the spread of the nicotinic
endplates (α-bungarotoxin/NF-200 positive units) per square millimeter, fol
High-magnification images of isolated motor endplates (α-bungarotoxin) sh
tube + PCL filaments (g), or tube + PCL filaments covered with MSC (h). Sca
n = 6 for each experimental conditiongroup showed similar morphology to the muscle of unle-
sioned rats (Fig. 6e–h).
Functional effects of PCL/MSC biomaterial in adult rats
with sciatic nerve lesion
The functional tests were performed 12 weeks after the
surgery in the three groups. The footprint area and max-
imum step intensity in the affected hind limb were com-
pared with the contralateral side and with the basal
values before sciatic nerve lesion (Fig. 7a–f ). The foot-
print area decreased to about 10–20 % of the pre-lesion
values in all the groups 1 week after the surgeries
(Fig. 7e). In all groups, recovery started 3 weeks after
surgery, but improvement was significantly faster in the
group that had received filaments plus MSC (p < 0.0001,
ANOVA). The step maximum intensity also showed fas-
ter and better improvement in the groups with fila-
ments, compared to the PBS group (Fig. 7f ). The swing
speed showed a similar pattern, with better performancegitudinal sections of the lateral gastrocnemius muscle labeled with
e lesion and implantation of hollow tube (a), tube + PCL filaments (b),
ll nuclei were stained with DAPI (blue). Arrows in a indicate the red
receptor. d Histogram of quantitative analysis of the number of motor
lowing the same experimental conditions as described above. e–h
owing the morphology observed for uninjured (e), hollow tube (f),
le bars: a–c = 200 μm; e–h = 20 μm. **p < 0.001, ***p < 0.0001, ANOVA;
Fig. 7 Functional benefits after the mesenchymal stem cell (MSC)/poly-caprolactone (PCL) biomaterial implants. a–d Footprint area and
maximum step intensity (range from green to red) as observed in the CatWalk system, in the normal limb (a) and in the injured limb of the three
groups of animals (b–d). e–g Histograms of correlation between the mean (ipsi/contralateral ratio) of the footprint area (e), maximum step
intensity (f), and swing speed (g), measured every week for 12 weeks. *,#,&p < 0.05, **,##,&&p < 0.001, ***,###p < 0.0001, ANOVA. *Tube versus MSC;
&tube versus PCL; #PCL versus MSC
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this set of experiments correlates the improvement in
motor functional recovery with increased axonal regen-
eration, myelination, and innervated motor endplates in
the animals that received the biomaterial containing fila-
ments covered by MSCs.
Discussion
The intrinsic regenerative capacity of the PNS is insuffi-
cient to completely restore its functions after extensive
lesions [5]. In these cases, nerve transplants are per-
formed in clinical practice, although this procedure in-
volves some negative aspects [2]. To overcome these
problems, new techniques of nerve tissue engineering
have been explored, including the use of several types of
conduits aiming to obtain equal or superior results com-
pared with autologous transplantation [3, 8].
In our study, we used PCL microstructured filaments
constructed to mimic the microarchitecture of a periph-
eral nerve, with six longitudinally oriented projections to
induce the alignment of the SC and the formation of
bands of Büngner in vitro. This composition forms per-
missive pathways for axonal regeneration and neurite
growth over the biomaterial [14, 36].
In addition to structural modifications of the materials,
the possibility of further improvement of axonal regener-
ation with cells was explored [17]. In many reports, bone
marrow-derived MSC have been used to increase per-
ipheral nerve regeneration by several mechanisms, which
include an increase in SC proliferation and in neuronalsurvival, and regrowth and remyelination of motor and
sensory axons [19–22].
Although some studies have demonstrated the inter-
action between PCL biomaterials and MSC, these studies
typically use nanofibers [37], nanofiber scaffolds [38] or
porous films [39]. The studies focus mainly on the
morphology that MSC adopt in contact with the mater-
ial, the maintenance of MSC multipotency [38], or com-
mitment to a specific differentiation phenotype [37, 39].
This study is the first to investigate the interaction be-
tween MSC and filaments having structural features on
a micrometric scale. The difference in scale enabled us
to develop a method of culture using a bundle of fila-
ments independent of any other culture surface, since
the cells that adhere to the filaments do not adhere to
the slide beneath it (Fig. 2). In studies that use PCL
nanofibers, due to the scale and organization of these
materials, the MSC, while adhering to the fibers, also
form adhesion foci to the substrate under the fibers.
Therefore, the micrometric structure used here could fa-
cilitate its implantation in vivo.
In the case of cell therapies combined with biomate-
rials, the number of cells used is highly important in
order to observe beneficial effects [40]. The initial
amount of MSC plated was enough to study its profile
of adhesion to PCL filaments. However, the concentra-
tion used was insufficient to obtain a material with high
cell density. Increasing the number of MSC plated
proved effective for augmenting the cell density and con-
sequently the covering of the filaments. However, when
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differently. In addition to aligning with the filaments,
they began to adhere to each other (Fig. 2). This kind of
adhesion increases the fragility of the attachment to the
material, since a complex of cells is held by only a few
cells that are directly attached to the filaments. Further-
more, the size of the cell cluster may act as a physical
barrier to the regeneration of peripheral nerves, prevent-
ing the formation of optimized bands of Büngner by SC
and reducing the available space for axonal extension.
The ability of MSC to adhere to the filaments does not
necessarily mean that their physiology remains un-
changed. Cell viability is an early indicator in this regard,
since if the cells do not maintain high viability, they are
less likely to produce beneficial effects. Cell viability was
high when MSC were cultured on PCL filaments, con-
tributing to the hypothesis that PCL filaments are not
toxic to these cells (Fig. 2f ). Even when cultured to-
gether with SC, a situation that would take place in vivo,
which could result in competition between them for
space and nutrients, both cell types maintained their
high rates of viability. The coexistence of SC in apparent
harmony with MSC in the established culture system
can be explained by recent evidence that SC are present
in certain niches of MSC [41], supporting the
hematopoietic stem cell niche [42].
The analysis of Ki67 labeling (Fig. 3) showed that PCL
filaments partially inhibit MSC proliferation when in dir-
ect contact. As the MSC are not in a traditional culture
system for expansion, such as the surface of a culture
plate, changes in their proliferation rate would be ex-
pected [37, 39]. It is possible that the morphology that
MSC adopt when adhering to the filaments could be
similar to that in their niche of origin. MSC proliferation
also assumes similar rates to those observed in vivo,
which indeed are low under physiological conditions
[43]. A long-term study in monkeys demonstrated that
MSC transplanted into a model PNS injury did not
cause tumors to form [44]. If the filaments were to in-
duce massive cell proliferation, the use of this in vivo
system could be impaired due to the increased possibil-
ity of tumor formation in the transplanted area. More-
over, their continued proliferation rate of 10 % could
contribute to the maintenance of cell renewal after
transplant, by replacing a percentage of cells that die,
thus maintaining their repair effect for a longer period
of time.
The MSC paracrine ability was inferred by analyzing
the production and secretion of FGF-2 (Fig. 3), since this
trophic factor is highly important to the SC during the
initial steps of Wallerian degeneration [26, 45]. The fact
that these cells produce FGF-2 when cultured on PCL
filaments, with only a small decrease in production, may
indicate that the interaction with the biomaterial is notcausing severe changes in their trophic activity. If these
kinds of modifications were taking place, it could indi-
cate an impairment of the paracrine effects of these cells
for the PNS regeneration.
Some studies have shown that, when plated on longi-
tudinally oriented nanofibers together with a cocktail of
inducing factors, MSC are able to assume a commitment
with neural phenotypes [45–47]. In the present study,
even though the morphology and the rate of prolifera-
tion of MSC changed, due to the short culture time on
the filaments (48 h) and the nonuse of inducing agents
in the culture medium, it is unlikely that these cells are
differentiating into a glial population. On the other
hand, the decreased rate of proliferation, and the fact
that they also express the CD90 membrane antigen and
are able to produce FGF-2, could indicate a commitment
to a repair phenotype [19].
Analysis of neurite outgrowth (Fig. 4) showed an in-
crease in the distance and alignment of neurites when
plated on filaments; these attributes can be extremely
important to guide axonal regeneration in vivo. This
alignment may prevent regenerating axons from growing
toward the walls of the conduit. The fact that DRG
neurites extend to greater distances when incubated on
PCL filament covered with MSC shows that, even in a
modified surface culture, MSC assist in the growth of
neurites and could be even more beneficial for the re-
generation of the PNS in vivo.
Detailed microscopic analysis showed that neurites
grow over the SC which migrate from DRG, as occurs
physiologically. Moreover, as the number of neurites in-
creased and they made contacts with MSC, these cells
can contribute to the permissive and correct pathway of
regeneration. Also, the further increase in the number of
neurites when MSC were incubated together with SC
may indicate a synergistic interaction within the entire
system.
Functional analysis by the CatWalk system (Fig. 7)
showed that the utilization of PCL filaments was at no
time detrimental to the animals in the parameters ana-
lyzed. Interestingly, the animals that received only the
filaments showed intermediate values between the other
two groups. In some cases they were closer to the values
of the group with MSC, and in others, closer to the
group in which only the lesion was performed. These
observations plus the improved performance of animals
with filaments and MSC clarify the importance of thera-
peutic effects with MSC in a model of critical injury of
the sciatic nerve. However, it appears that the structural
support offered by PCL filaments in events such as the
induction of bands of Büngner by SC or axonal regener-
ation may be of great importance for the development of
strategies for the regeneration of extensive nerve seg-
ments. The observation that PCL filaments covered by
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motor endplates suggests that this biomaterial was bene-
ficial not only during acute periods of PNS regeneration,
but also during the final steps of nerve regeneration
(Fig. 6).
The temporal analysis showed that the eighth week
after the injury is an important timeframe for regener-
ation in the lesion model used. Only animals that re-
ceived PCL filaments with MSC did not show a
regression in functional parameters at that time. One ex-
planation for this may be that MSC, through their re-
generative effect, induced a necessary prerequisite for
effective regeneration of the PNS, such as acceleration
or stabilization of axonal growth, thus preventing the
functional regression observed in the other groups.
Twelve weeks after injury, the consequences of a crit-
ical injury to the sciatic nerve were evident (Fig. 5).
Nerves of the “tube” group showed a frail regenerated
tissue, with less cell density, consisting of few elements,
such as fibroblasts, a few SC in the periphery, and se-
creted extracellular matrix molecules. Nerves of the “fil-
aments” and “filaments +MSC” groups appeared to be
more robust because of their increased cellularity and
the presence of filaments, and showed greater SC migra-
tion and axonal regeneration. The more organized ap-
pearance of the tissue in the latter group may be a result
of an increased maturation of the SC and stabilization of
the axon by the reinnervation of the respective motor
plate, induced by the MSC. Still, more detailed histo-
logical analysis will be needed in order to investigate the
degree of remyelinization and the consequences to the
neurons in the DRG and lumbar spinal cord, which pro-
ject axons to the sciatic nerve, in each experimental
group.
Conclusion
In summary, this study contributes new information on
the use of microstructured PCL filaments together with
MSC for the regeneration of severe peripheral nerve in-
juries. Interaction with PCL filaments induces morpho-
logical and physiological changes in MSC, and positively
modulates neurite outgrowth and alignment. This is the
first time that these PCL filaments have been implanted
in a model of critical lesion of the PNS, showing the
feasibility of their use, the functional benefits and the
histological organization of the regenerated nerve tissue,
when combined with MSC.
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Additional file 1: Figure S1. Cell viability in the presence of PCL
filaments. A–H: Calcein/ethidium (live/dead) assay analyzed by
fluorescence microscopy of MSCs co-cultured or not with Schwann cells
(previously incubated with CellTrace) on the PCL filaments. A,B: Live cellsrevealed by calcein fluorescence of MSC (A) or MSC with Schwann cells
(B). C,D: Dead cells revealed by ethidium fluorescence of MSC (C) or MSC
with Schwann cells (D). CellTrace fluorescence of Schwann cells is observed
in F (co-cultured with MSC) but not in E (only MSC). G,H: Merged images of
calcein, ethidium and CellTrace, allowing the detection of MSC viability
under both culture conditions. Scale bars: A–H = 400 μm.
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